Pay in 4 interest-free payments of $32.50 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Epub 2012 Feb 1
Treatment with a combination of enzastaurin and the GSK3 inhibitor AR-A014418 leads to increased levels of β-catenin total protein and β-catenin-mediated transcription
Atipamezole alters the behavioural effects of pramipexole and increases pramipexole concentration in blood plasma
Prinaberel shows a marked reduction in the expression of inflammation regulatory proteins such as p-NFκBp65
9)3(6)4(7)8/h3
N-Desethyl Sunitinib Size:Solid 10 mg Epub 2012 Feb 1N Desethyl Sunitinib is a metabolite of sunitinib. Sunitinib is a potent, ATP competitive VEGFR, PDGFR and KIT inhibitor with Ki values of 2, 9, 17, 8 and 4 nM for VEGFR 1, 2, 3, PDGFR and KIT, respectively. Sunitinib also potently inhibits Kit and FLT 3. Sunitinib inhibits VEGF induced proliferation of serum starved HUVECs with IC50 of 40 nM, and inhibits PDGF induced proliferation of NIH 3T3 cells overexpressing PDGFR or PDGFR with IC50 of 39 nM and